Cart (0 Items)
Your cart is currently empty.
View ProductsSize | 100ug |
---|---|
Brand | Arovia |
Product type | Recombinant Proteins |
Product name | Recombinant Human FGF16 Protein, N-His-SUMO |
---|---|
Origin species | Human |
Expression system | Prokaryotic expression |
Molecular weight | 32.52 kDa |
Buffer | Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol. |
Form | Liquid |
Delivery condition | Dry Ice |
Delivery lead time in business days | 3-5 days if in stock; 3-5 weeks if production needed |
Storage condition | 4°C for short term (1 week), -20°C or -80°C for long term (avoid freezing/thawing cycles; addition of 20-40% glycerol improves cryoprotection) |
Brand | Arovia |
Host species | Escherichia coli (E.coli) |
Fragment Type | Asn35-Arg207 |
Aliases /Synonyms | FGF-16, Fibroblast growth factor 16, FGF16 |
Reference | ARO-P11539 |
Note | For research use only. |
Recombinant Human FGF16 Protein is a type of recombinant protein that has been engineered through genetic manipulation to mimic the structure and function of the human fibroblast growth factor 16 (FGF16) protein. This protein plays a crucial role in various biological processes, making it a valuable tool in scientific research and potential therapeutic applications. In this article, we will explore the structure, activity, and potential applications of Recombinant Human FGF16 Protein.
Recombinant Human FGF16 Protein is a 21-kDa protein consisting of 192 amino acids. It shares a high degree of sequence similarity with other members of the FGF family, particularly with FGF2 and FGF9. The protein has a conserved core region, which is responsible for its biological activity, and a variable N-terminal region, which determines its specificity for different receptors.
The crystal structure of Recombinant Human FGF16 Protein has been determined, revealing a compact globular structure with 12 beta strands and 6 alpha helices. The protein also contains two disulfide bonds, which are essential for its stability and activity.
Recombinant Human FGF16 Protein is a potent mitogen, meaning it stimulates cell division and proliferation. It exerts its effects by binding to specific cell surface receptors, known as FGF receptors (FGFRs). These receptors are present on the surface of various cell types, including epithelial, endothelial, and mesenchymal cells.
Upon binding to FGFRs, Recombinant Human FGF16 Protein triggers a cascade of signaling events that ultimately lead to cell growth, survival, and differentiation. It also plays a role in angiogenesis, the process of forming new blood vessels, by stimulating the proliferation of endothelial cells.
In addition to its mitogenic activity, Recombinant Human FGF16 Protein has been shown to have neurotrophic and neuroprotective effects. It promotes the survival and differentiation of neurons, making it a potential therapeutic agent for neurodegenerative diseases.
Recombinant Human FGF16 Protein has a wide range of applications in scientific research and potential therapeutic use. Here are some of its most notable applications:
Recombinant Human FGF16 Protein is commonly used in cell culture studies to investigate its effects on cell growth, survival, and differentiation. It is also used to study the signaling pathways activated by FGF16 and its interactions with other growth factors and cytokines.
Due to its mitogenic and angiogenic properties, Recombinant Human FGF16 Protein has been explored as a potential growth factor for tissue engineering applications. It has been shown to promote the proliferation and differentiation of various cell types, including stem cells, making it a promising candidate for tissue regeneration.
Recombinant Human FGF16 Protein has been investigated for its potential in promoting wound healing. It has been shown to accelerate the healing process by stimulating the proliferation of epithelial cells and the formation of new blood vessels.
As mentioned earlier, Recombinant Human FGF16 Protein has neurotrophic and neuroprotective effects, making it a potential therapeutic agent for neurodegenerative diseases such as Alzheimer’s and Parkinson’s. It has been shown to promote neuronal survival and differentiation, and further research is being conducted to explore its potential in treating these diseases.
Aberrant FGF signaling has been linked to various types of cancer, making Recombinant Human FGF16 Protein a valuable tool in cancer research. It has been used to investigate the role of FGF16 in cancer development and progression and to develop potential targeted therapies.
<h2
Send us a message from the form below
Reviews
There are no reviews yet.